BioSpace News Archive

Phizzle Introduces First Data Transformation Engine for BioPharma/GMP Use; Makes it Possible to Harmonize Data into any LIMs from any Instrument

At the BioTalk Conference near Boston, Phizzle, Inc., today introduced the industry’s first Data Transformation Engine, a software innovation that makes it possible to harmonize data from different lab instruments into any standard LIMs -- closing a major gap in data integrity for BioPharma manufacturers.

May 7, 2024
·
1 min read
PumasAI Named Best Clinical Pharmacology Technology Development Firm in Biotechnology Awards

PumasAI, a science-first organization and a trailblazer in clinical pharmacology technology, has been honored as the “Best Clinical Pharmacology Technology Development Firm” at the prestigious Biotechnology Awards

May 7, 2024
·
3 min read
Antipsychotic Drugs Market Size to Capture USD 37.40 Billion by 2032

The antipsychotic drugs market was valued at USD 18.04 billion in 2023 and is expected to reach around USD 37.40 billion by 2032, rising at a CAGR of 7.8% from 2024 to 2032.

May 7, 2024
·
9 min read
Liver Cancer Drugs Market Size to Capture USD 9.94 Bn Leading at 14.2% of CAGR by 2032

The liver cancer drugs market size was worth USD 2.67 billion in 2023 is expected to grow to USD 9.94 billion by 2032, rising with a CAGR of 14.2% from 2024 to 2032.

May 7, 2024
·
10 min read
Biotech Beach

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024

Regen BioPharma, Inc., a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on May 9, 2024.

May 7, 2024
·
3 min read
Biotech Bay

Lyell Immunopharma to Participate in BofA Securities Health Care Conference 2024

Lyell Immunopharma, Inc. announced that members of its senior management team will participate in the BofA Securities 2024 Health Care Conference on Tuesday, May 14 at 8:40 am PT.

May 7, 2024
·
1 min read
Business

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

Taysha Gene Therapies, Inc. announced that it will report its financial results for the first quarter ended March 31, 2024, and host a corporate update conference call and webcast on Tuesday, May 14, 2024, at 4:30 PM Eastern Time.

May 7, 2024
·
1 min read
Business

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024

TRACON Pharmaceuticals, Inc. announced that it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024.

May 7, 2024
·
2 min read
Business

QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics

QIAGEN announced a cooperative research and development agreement with the U.S. Federal Bureau of Investigation to develop a novel test for its QIAcuity digital PCR devices that will boost forensics by improving the quantification of DNA in human samples.

May 7, 2024
·
8 min read
Business

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Aligos Therapeutics, Inc. reported recent business progress and financial results for the first quarter 2024.

May 7, 2024
·
9 min read